PDA TR 81 focuses on the development of a risk-based control strategy adapted to cell-based therapy that can mitigate the risk of generating a product of poor quality.
More Standards PDF
PIP ARS08111
$50.00 $100.00
PIP CTCE1000
$75.00 $150.00
PIP PN01SA0J01
$37.00 $75.00
PIP ELSPS01V-EEDS
$25.00 $50.00